e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Venous thromboembolism
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Heparin-induced thrombocytopenia in patients with massive lung embolism, left-sided pneumonia and uterine tumor
M. Rozek, A. Doboszynska, E. Sosnowska, I. Tomaszewska (Warsaw, Poland)
Source:
Annual Congress 2007 - Venous thromboembolism
Session:
Venous thromboembolism
Session type:
Thematic Poster Session
Number:
623
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Rozek, A. Doboszynska, E. Sosnowska, I. Tomaszewska (Warsaw, Poland). Heparin-induced thrombocytopenia in patients with massive lung embolism, left-sided pneumonia and uterine tumor. Eur Respir J 2007; 30: Suppl. 51, 623
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
The causes of hemoptysis and lung hemorrhage in patients with pulmonary sarcoidosis
Source: Annual Congress 2011 - Acute respiratory failure
Year: 2011
How severe pulmonary hemorrhage influence on surgical tactics at patients with lung abscess and gangrene?
Source: Annual Congress 2012 - Surgery for infections and congenital diseases
Year: 2012
Recurrent massive pulmonary hemorrhage in the course of hereditary hemorrhagic teleangiectasia (HHT) with diffuse pulmonary arteriovenous malformations
Source: Annual Congress 2009 - Interesting case reports and case series
Year: 2009
Recurrence and bleeding in the extended treatment of patients with pulmonary embolism (PE) and cancer
Source: International Congress 2018 – Diagnosis, prognostication and treatment of pulmonary embolism
Year: 2018
Five cases of breast cancer complicated with pulmonary embolism
Source: Eur Respir J 2006; 28: Suppl. 50, 45s
Year: 2006
A case of lung cancer complicated with pulmonary thromboemboli
Source: Eur Respir J 2006; 28: Suppl. 50, 93s
Year: 2006
A patient with pancreatitis, anaemia and an intrathoracic tumour
Source: Eur Respir J 2006; 27: 856-859
Year: 2006
A rare and misleading cause of lung nodules with pulmonary embolism
Source: International Congress 2019 – CCC Interstitial lung diseases
Year: 2019
A case of pulmonary choriocarcinoma presenting as a pulmonary thromboembolism
Source: Virtual Congress 2020 – Pulmonary vascular diseases
Year: 2020
PP312 – Diagnosis of non severe pulmonary embolism
Source: ERS Lung Science Conference 2021
Year: 2021
Persistent lung perfusion defect is a risk factor for recurrent venous thromboembolism after pulmonary embolism
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012
Characteristics of massive and other than massive embolism patients
Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases
Year: 2009
Pulmonary vasculitis presenting as acute diffuse alveolar haemorrhage (DAH)
Source: International Congress 2018 – CC5 Pulmonary vasculitis: the great chameleon
Year: 2018
What is the incidence of pleural effusions in acute pulmonary emboli?
Source: Virtual Congress 2020 – Pulmonary embolism
Year: 2020
The shock index and the simplified PESI for identification of low-risk patients with acute pulmonary embolism
Source: Eur Respir J 2011; 37: 762-766
Year: 2011
A rare pulmonary zygomycosis manifested as chronic mediastinitis and bronchial perforation
Source: Eur Respir J 2011; 38: 734-735
Year: 2011
Management of life-threatening hemoptysis in chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2003; 22: Suppl. 45, 221s
Year: 2003
Fibrinolysis with tenecteplase in the management of massive pulmonary embolism
Source: Eur Respir J 2004; 24: Suppl. 48, 559s
Year: 2004
Fibrinogen and the prediction of residual obstruction manifested after pulmonary embolism treatment
Source: Eur Respir J, 52 (5) 1801467; 10.1183/13993003.01467-2018
Year: 2018
Chronic thromboembolic pulmonary hypertension in patients who underwent acute pulmonary embolic event preceded by unrecognised recurrences
Source: Eur Respir J 2006; 28: Suppl. 50, 45s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept